Provided by Tiger Trade Technology Pte. Ltd.

Prime Medicine, Inc.

3.90
+0.400011.43%
Post-market: 3.88-0.0162-0.42%19:57 EDT
Volume:11.20M
Turnover:42.67M
Market Cap:703.99M
PE:-3.59
High:4.02
Open:3.36
Low:3.30
Close:3.50
52wk High:6.85
52wk Low:2.67
Shares:180.51M
Float Shares:116.00M
Volume Ratio:2.26
T/O Rate:9.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0853
EPS(LYR):-1.3521
ROE:-373.29%
ROA:-46.52%
PB:17.68
PE(LYR):-2.88

Loading ...

NextCure Q2 Net Loss Narrows on Lower Expenses

Reuters
·
Aug 07

INmune Bio Q2 Net Loss Narrows on Lower Impairment Charges

Reuters
·
Aug 07

Prime Medicine, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Prime Medicine Publishes Corporate Presentation on Prime Editing Platform, Liver Disease Pipeline Focus

Reuters
·
Aug 06

Prime Medicine, Inc. Q2 EPS USD -0.24

Reuters
·
Aug 06

Prime Medicine Q2 FY26 Net Loss Narrows to $42.1 Million

Reuters
·
Aug 06

Prime Medicine Q2 EPS $(0.24) Beats $(0.26) Estimate, Sales $1.154M Miss $1.295M Estimate

Benzinga Earnings
·
Aug 06

Press Release: Prime Medicine Reports Second Quarter 2026 Financial Results and Provides Business Updates

Dow Jones
·
Aug 06

Prime Medicine, Inc. Q2 Income from Operations USD -43.285 Million

THOMSON REUTERS
·
Aug 06

Prime Medicine, Inc: Expects Cash and Investments as of June 30, 2026 Sufficient to Fund Operations into 2027

THOMSON REUTERS
·
Aug 06

Scribe's Genetic Editing Aims to Prevent Heart Attacks

Dow Jones
·
Jul 30

Prime Medicine Says FDA Clears IND for Pm577a in Wilson Disease Trial

Reuters
·
Jul 24

Prime Medicine Announces U.S. FDA Clearance of Investigational New Drug Application for Pm577a in H1069q-mutated Wilson Disease

THOMSON REUTERS
·
Jul 24

Prime Medicine, - Phase 1/2 Trial for Pm577a Expected to Start in H2 2026 with Initial Data in 2027

THOMSON REUTERS
·
Jul 24

LifeSci Capital Remains a Buy on Prime Medicine, Inc. (PRME)

TIPRANKS
·
Jul 11

Prime Medicine Down Nearly 14%, on Pace for Largest Percent Decrease Since May 2025

Dow Jones
·
Jul 10

TD Cowen says arbitration decision removes overhang for Prime Medicine’s PM647

TIPRANKS
·
Jul 09

Resolution in favor of Prime has limited impact to Beam, says BofA

TIPRANKS
·
Jul 08

Analysts Offer Insights on Healthcare Companies: Resmed (RMD) and Prime Medicine, Inc. (PRME)

TIPRANKS
·
Jul 08

Prime Medicine Posts Corporate Deck Highlighting Prime-editing Platform, Lead Programs in Wilson Disease and AATD

Reuters
·
Jul 08